Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
The Role of Pharmacogenomics in Contemporary Cardiovascular Therapy: A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

European heart journal. Cardiovascular pharmacotherapy

Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ.
PMID: 33638977
Eur Heart J Cardiovasc Pharmacother. 2021 Feb 26; doi: 10.1093/ehjcvp/pvab018. Epub 2021 Feb 26.

There is a strong and ever-growing body of evidence regarding the use of pharmacogenomics to inform cardiovascular pharmacology. However, there is no common position taken by international cardiovascular societies to unite diverse availability, interpretation and application of such data,...

Cite
Magavern EF, Kaski JC, Turner RM, et al. The Role of Pharmacogenomics in Contemporary Cardiovascular Therapy: A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2021;doi: 10.1093/ehjcvp/pvab018.
Magavern, E. F., Kaski, J. C., Turner, R. M., Drexel, H., Janmohamed, A., Scourfield, A., Burrage, D., Floyd, C. N., Adeyeye, E., Tamargo, J., Lewis, B. S., Kjeldsen, K. P., Niessner, A., Wassmann, S., Sulzgruber, P., Borry, P., Agewall, S., Semb, A. G., Savarese, G., Pirmohamed, M., & Caulfield, M. J. (2021). The Role of Pharmacogenomics in Contemporary Cardiovascular Therapy: A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European heart journal. Cardiovascular pharmacotherapy, . https://doi.org/10.1093/ehjcvp/pvab018
Magavern, E F, et al. "The Role of Pharmacogenomics in Contemporary Cardiovascular Therapy: A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy." European heart journal. Cardiovascular pharmacotherapy vol. (2021). doi: https://doi.org/10.1093/ehjcvp/pvab018
Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ. The Role of Pharmacogenomics in Contemporary Cardiovascular Therapy: A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2021 Feb 26; doi: 10.1093/ehjcvp/pvab018. Epub 2021 Feb 26. PMID: 33638977.
Copy Download .nbib Format: NLM
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

European heart journal. Cardiovascular pharmacotherapy

Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ.
PMID: 33638977
Eur Heart J Cardiovasc Pharmacother. 2022 Jan 05;8(1):85-99. doi: 10.1093/ehjcvp/pvab018.

There is a strong and ever-growing body of evidence regarding the use of pharmacogenomics to inform cardiovascular pharmacology. However, there is no common position taken by international cardiovascular societies to unite diverse availability, interpretation, and application of such data,...

Cite
Magavern EF, Kaski JC, Turner RM, et al. The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2022;8(1):85-99doi: 10.1093/ehjcvp/pvab018.
Magavern, E. F., Kaski, J. C., Turner, R. M., Drexel, H., Janmohamed, A., Scourfield, A., Burrage, D., Floyd, C. N., Adeyeye, E., Tamargo, J., Lewis, B. S., Kjeldsen, K. P., Niessner, A., Wassmann, S., Sulzgruber, P., Borry, P., Agewall, S., Semb, A. G., Savarese, G., Pirmohamed, M., & Caulfield, M. J. (2022). The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European heart journal. Cardiovascular pharmacotherapy, 8(1), 85-99. https://doi.org/10.1093/ehjcvp/pvab018
Magavern, Emma Forton, et al. "The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy." European heart journal. Cardiovascular pharmacotherapy vol. 8,1 (2022): 85-99. doi: https://doi.org/10.1093/ehjcvp/pvab018
Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ. The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 05;8(1):85-99. doi: 10.1093/ehjcvp/pvab018. PMID: 33638977.
Copy Download .nbib Format: NLM
Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma.

Scientific reports

Jones CL, Degasperi A, Grandi V, Amarante TD, Mitchell TJ, Nik-Zainal S, Whittaker SJ.
PMID: 33597573
Sci Rep. 2021 Feb 17;11(1):3962. doi: 10.1038/s41598-021-83352-4.

T-cell non-Hodgkin's lymphomas develop following transformation of tissue resident T-cells. We performed a meta-analysis of whole exome sequencing data from 403 patients with eight subtypes of T-cell non-Hodgkin's lymphoma to identify mutational signatures and associated recurrent gene mutations. Signature...

Cite
Jones CL, Degasperi A, Grandi V, et al. Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma. Sci Rep. 2021;11(1):3962doi: 10.1038/s41598-021-83352-4.
Jones, C. L., Degasperi, A., Grandi, V., Amarante, T. D., Mitchell, T. J., Nik-Zainal, S., & Whittaker, S. J. (2021). Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma. Scientific reports, 11(1), 3962. https://doi.org/10.1038/s41598-021-83352-4
Jones, Christine L, et al. "Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma." Scientific reports vol. 11,1 (2021): 3962. doi: https://doi.org/10.1038/s41598-021-83352-4
Jones CL, Degasperi A, Grandi V, Amarante TD, Mitchell TJ, Nik-Zainal S, Whittaker SJ. Spectrum of mutational signatures in T-cell lymphoma reveals a key role for UV radiation in cutaneous T-cell lymphoma. Sci Rep. 2021 Feb 17;11(1):3962. doi: 10.1038/s41598-021-83352-4. PMID: 33597573; PMCID: PMC7889847.
Copy Download .nbib Format: NLM
Genomic medicine: time for health-care transformation.

Lancet (London, England)

Scott RH, Fowler TA, Caulfield M.
PMID: 31395438
Lancet. 2019 Aug 10;394(10197):454-456. doi: 10.1016/S0140-6736(19)31796-9. Epub 2019 Aug 05.

No abstract available.

Cite
Scott RH, Fowler TA, Caulfield M. Genomic medicine: time for health-care transformation. Lancet. 2019;394(10197):454-456doi: 10.1016/S0140-6736(19)31796-9.
Scott, R. H., Fowler, T. A., & Caulfield, M. (2019). Genomic medicine: time for health-care transformation. Lancet (London, England), 394(10197), 454-456. https://doi.org/10.1016/S0140-6736(19)31796-9
Scott, Richard H, et al. "Genomic medicine: time for health-care transformation." Lancet (London, England) vol. 394,10197 (2019): 454-456. doi: https://doi.org/10.1016/S0140-6736(19)31796-9
Scott RH, Fowler TA, Caulfield M. Genomic medicine: time for health-care transformation. Lancet. 2019 Aug 10;394(10197):454-456. doi: 10.1016/S0140-6736(19)31796-9. Epub 2019 Aug 05. PMID: 31395438.
Copy Download .nbib Format: NLM
Hypertension due to a deoxycorticosterone-secreting adrenal tumour diagnosed during pregnancy.

Endocrinology, diabetes & metabolism case reports

Marques P, Tufton N, Bhattacharya S, Caulfield M, Akker SA.
PMID: 31051469
Endocrinol Diabetes Metab Case Rep. 2019 May 03;2019. doi: 10.1530/EDM-18-0164. Epub 2019 May 03.

Mineralocorticoid hypertension is most often caused by autonomous overproduction of aldosterone, but excess of other mineralocorticoid precursors can lead to a similar presentation. 11-Deoxycorticosterone (DOC) excess, which can occur in 11-β hydroxylase or 17-α hydroxylase deficiencies, in DOC-producing adrenocortical...

Cite
Marques P, Tufton N, Bhattacharya S, et al. Hypertension due to a deoxycorticosterone-secreting adrenal tumour diagnosed during pregnancy. Endocrinol Diabetes Metab Case Rep. 2019;2019doi: 10.1530/EDM-18-0164.
Marques, P., Tufton, N., Bhattacharya, S., Caulfield, M., & Akker, S. A. (2019). Hypertension due to a deoxycorticosterone-secreting adrenal tumour diagnosed during pregnancy. Endocrinology, diabetes & metabolism case reports, 2019. https://doi.org/10.1530/EDM-18-0164
Marques, Pedro, et al. "Hypertension due to a deoxycorticosterone-secreting adrenal tumour diagnosed during pregnancy." Endocrinology, diabetes & metabolism case reports vol. 2019 (2019). doi: https://doi.org/10.1530/EDM-18-0164
Marques P, Tufton N, Bhattacharya S, Caulfield M, Akker SA. Hypertension due to a deoxycorticosterone-secreting adrenal tumour diagnosed during pregnancy. Endocrinol Diabetes Metab Case Rep. 2019 May 03;2019. doi: 10.1530/EDM-18-0164. Epub 2019 May 03. PMID: 31051469; PMCID: PMC6499913.
Copy Download .nbib Format: NLM
The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

European heart journal. Cardiovascular pharmacotherapy

Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ.
PMID: 33638977
Eur Heart J Cardiovasc Pharmacother. 2022 Jan 05;8(1):85-99. doi: 10.1093/ehjcvp/pvab018.

There is a strong and ever-growing body of evidence regarding the use of pharmacogenomics to inform cardiovascular pharmacology. However, there is no common position taken by international cardiovascular societies to unite diverse availability, interpretation, and application of such data,...

Cite
Magavern EF, Kaski JC, Turner RM, et al. The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2022;8(1):85-99doi: 10.1093/ehjcvp/pvab018.
Magavern, E. F., Kaski, J. C., Turner, R. M., Drexel, H., Janmohamed, A., Scourfield, A., Burrage, D., Floyd, C. N., Adeyeye, E., Tamargo, J., Lewis, B. S., Kjeldsen, K. P., Niessner, A., Wassmann, S., Sulzgruber, P., Borry, P., Agewall, S., Semb, A. G., Savarese, G., Pirmohamed, M., & Caulfield, M. J. (2022). The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. European heart journal. Cardiovascular pharmacotherapy, 8(1), 85-99. https://doi.org/10.1093/ehjcvp/pvab018
Magavern, Emma Forton, et al. "The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy." European heart journal. Cardiovascular pharmacotherapy vol. 8,1 (2022): 85-99. doi: https://doi.org/10.1093/ehjcvp/pvab018
Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ. The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2022 Jan 05;8(1):85-99. doi: 10.1093/ehjcvp/pvab018. PMID: 33638977.
Copy Download .nbib Format: NLM
Using data from the 100,000 Genomes Project to resolve conflicting interpretations of a recurrent .

Journal of medical genetics

Ragoussis V, Pagnamenta AT, Haines RL, Giacopuzzi E, McClatchey MA, Sampson JR, Suri M, Gardham A, Cobben JM, Osio D, Fry AE, Taylor JC.
PMID: 33547136
J Med Genet. 2021 Feb 05; doi: 10.1136/jmedgenet-2020-107528. Epub 2021 Feb 05.

No abstract available.

Cite
Ragoussis V, Pagnamenta AT, Haines RL, et al. Using data from the 100,000 Genomes Project to resolve conflicting interpretations of a recurrent . J Med Genet. 2021;doi: 10.1136/jmedgenet-2020-107528.
Ragoussis, V., Pagnamenta, A. T., Haines, R. L., Giacopuzzi, E., McClatchey, M. A., Sampson, J. R., Suri, M., Gardham, A., Cobben, J. M., Osio, D., Fry, A. E., & Taylor, J. C. (2021). Using data from the 100,000 Genomes Project to resolve conflicting interpretations of a recurrent . Journal of medical genetics, . https://doi.org/10.1136/jmedgenet-2020-107528
Ragoussis, Vassilis, et al. "Using data from the 100,000 Genomes Project to resolve conflicting interpretations of a recurrent ." Journal of medical genetics vol. (2021). doi: https://doi.org/10.1136/jmedgenet-2020-107528
Ragoussis V, Pagnamenta AT, Haines RL, Giacopuzzi E, McClatchey MA, Sampson JR, Suri M, Gardham A, Cobben JM, Osio D, Fry AE, Taylor JC. Using data from the 100,000 Genomes Project to resolve conflicting interpretations of a recurrent . J Med Genet. 2021 Feb 05; doi: 10.1136/jmedgenet-2020-107528. Epub 2021 Feb 05. PMID: 33547136.
Copy Download .nbib Format: NLM
An online compendium of treatable genetic disorders.

American journal of medical genetics. Part C, Seminars in medical genetics

Bick D, Bick SL, Dimmock DP, Fowler TA, Caulfield MJ, Scott RH.
PMID: 33350578
Am J Med Genet C Semin Med Genet. 2021 Mar;187(1):48-54. doi: 10.1002/ajmg.c.31874. Epub 2020 Dec 22.

More than 4,000 genes have been associated with recognizable Mendelian/monogenic diseases. When faced with a new diagnosis of a rare genetic disorder, health care providers increasingly turn to internet resources for information to understand the disease and direct care....

Cite
Bick D, Bick SL, Dimmock DP, et al. An online compendium of treatable genetic disorders. Am J Med Genet C Semin Med Genet. 2020;187(1):48-54doi: 10.1002/ajmg.c.31874.
Bick, D., Bick, S. L., Dimmock, D. P., Fowler, T. A., Caulfield, M. J., & Scott, R. H. (2021). An online compendium of treatable genetic disorders. American journal of medical genetics. Part C, Seminars in medical genetics, 187(1), 48-54. https://doi.org/10.1002/ajmg.c.31874
Bick, David, et al. "An online compendium of treatable genetic disorders." American journal of medical genetics. Part C, Seminars in medical genetics vol. 187,1 (2021): 48-54. doi: https://doi.org/10.1002/ajmg.c.31874
Bick D, Bick SL, Dimmock DP, Fowler TA, Caulfield MJ, Scott RH. An online compendium of treatable genetic disorders. Am J Med Genet C Semin Med Genet. 2021 Mar;187(1):48-54. doi: 10.1002/ajmg.c.31874. Epub 2020 Dec 22. PMID: 33350578; PMCID: PMC7986124.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries